Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. MEDX: which is better?

Bottom line

XLV vs MEDX: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and MEDX (Horizon Kinetics Medical ETF) share a meaningful slice of their top holdings — about 47% by weight.

XLV is cheaper at 0.08% vs 0.85% — a difference of $77 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +5.8% for MEDX.

Updated Nov 19, 2026

XLV vs MEDX side by side

XLVMEDX
TypeETFETF
Fund familySPDR (State Street)Roundhill
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%0.85%
Annual cost per $10k$8$85
10-yr cost on $10k (prospectus)$103$1,049
Max front loadNoneNone
12b-1 fee0.02%0%
1-yr return+14.5%+28.4%
5-yr return (annualized)+8.1%+5.8%
10-yr return (annualized)+9.8%+5.7%
Best quarter+14.5%+15.0%
Worst quarter−12.7%−12.9%
Net assets (fund)$40.6B$19.1M
Number of holdings6533
Portfolio turnover2%%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXLVMEDXDifference
2025+14.5%+28.4%−13.9%
2024+2.5%−4.7%+7.2%
2023+2.0%−6.0%+8.0%
2022−2.1%+4.2%−6.3%
2021+25.9%+10.6%+15.3%
2020+13.3%+9.0%+4.2%
2019+20.7%+16.0%+4.6%
2018+6.3%+1.7%+4.6%
2017+21.7%+10.7%+11.0%
2016−2.8%−8.0%+5.2%

Source: Fund prospectus bar charts

Holdings overlap

8 of XLV's top 25 holdings also appear in MEDX's top 25.

Shared top holdings
HoldingXLVMEDX
Eli Lilly & Co16.51%18.46%
Johnson & Johnson10.64%5.59%
AbbVie Inc7.74%8.85%
Merck & Co Inc5.52%3.96%
Amgen Inc3.40%3.91%
Pfizer Inc2.39%2.86%
Bristol-Myers Squibb Co2.05%4.42%
Regeneron Pharmaceuticals Inc1.08%2.06%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

MEDX top 10

  1. Eli Lilly & Co — 18.46%
  2. US Bank Mmda - Usbgfs 7 — 9.19%
  3. AbbVie Inc — 8.85%
  4. Novartis AG — 6.89%
  5. Johnson & Johnson — 5.59%
  6. Alkermes PLC — 5.53%
  7. AstraZeneca PLC — 4.98%
  8. Ionis Pharmaceuticals Inc — 4.53%
  9. Bristol-Myers Squibb Co — 4.42%
  10. Merck & Co Inc — 3.96%

FAQ

What is the difference between XLV and MEDX?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and MEDX (Horizon Kinetics Medical ETF) share a meaningful slice of their top holdings — about 47% by weight. XLV is cheaper at 0.08% vs 0.85% — a difference of $77 a year per $10,000 invested.
Which is cheaper, XLV or MEDX?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and MEDX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.